Categories
Tags
multiple sclerosis
- DateAugust 15, 2017MS is an immune-mediated demyelinating disorder with a neurodegenerative component. While most of the current therapeutic approaches are immunomodulatory, there is a definite interest and urgent effort to identify novel treatments to promote myelin repair and restore function…
Moderators
Bruce Bebo, PhDNational Multiple Sclerosis SocietyPatrizia Casaccia, MD, PhDIcahn School of Medicine / Advanced Science Research Center at GC-CUNYPanelists
Dennis Bourdette, MDOregon Health & Science UniversityAri Green, MDUniversity of California, San FranciscoAndrew L. Goodman, PhDYale School of MedicineDouglas Landsman, PhDAssociate Vice President, Biomedical Research, National Multiple Sclerosis SocietyFreeStandard Price